Home DM² NB Application Access

Electronic Patient Management

Our electronic patient management tool gives a patients' physician an easy algorithmic approach to the latest treatment guidelines pertaining to type 2 diabetes across all organ spectrums.

The People

Principle Investigators

  • Christine Pippy, M.D., MSc, F.R.C.P.C.
  • Jennifer Ryan, BSc.Pharm, Pharm D, ACPR
  • Valerie Price, RN CNeph(c)

Partners and Sponsors

The team at DM2 would like to thank our many partners.

  • The Province of New Brunswick - in-kind support
  • Pharmaceutical & Industry Partners
    Amgen, The Anyware Group, AstraZeneca Canada, BioVail, Bristol-Myers Squibb, Genzyme Canada, Glaxo Smith Kline, Merck, Novo Nordisk Canada Inc., Ortho-Biotech, Pfizer, Roche, Sanofi Aventis, Servier
  • Research Department Atlantic Health Sciences Corporation - Ethics Research Review
  • The core medical group - developed the treatment algorithm, project inception and is responsible for implementation

Welcome to DM² New Brunswick